Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ViroMed Co Ltd

+ Add to Watchlist

084990:KS

141,300 KRW 6,400 4.74%

As of 02:28:30 ET on 05/28/2015.

Snapshot for ViroMed Co Ltd (084990)

Open: 137,500 Day's Range: 134,000 - 141,900 Volume: 194,205
Previous Close: 134,900 52wk Range: 43,200 - 153,500 1-Yr Rtn: +186.03%

Stock Chart for 084990

No chart data available.
  • 084990:KS 140,600
  • 1D
  • 1M
  • 1Y
134,900
Interactive 084990 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 084990

Current P/E Ratio (ttm) 7,436.8421
Estimated P/E(-) -
Relative P/E vs. KOSPI 403.5185
Earnings Per Share (ttm) 19.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 2,006,160.02
Shares Outstanding (M) 14.20
30 Day Average Volume 381,428
Price/Book (mrq) 29.9569
Price/Sale (ttm) 346.9921
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 084990

No data available

Company Profile & Key Executives for 084990

ViroMed Company Ltd., develops biopharmaceutical products using recombinant DNA and other technologies. The Company is developing therapeutics in the areas of cardiovascular disease, cancer, and immune disorder.

Kim Yong-SooCEO/Rep DirectorKim Sun-YoungPresident
Kim Sung-ChulExecutive DirectorSong Hah-ZoongExecutive Director
More Company Profile & Key Executives for 084990

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil